Milton spares Florida factory that’s critical supplier of IV fluids

  • Comments
  • Print
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

A Florida factory that makes IV fluids critical to hospitals nationwide will restart Friday morning after shutting down while Hurricane Milton tore through the state.

B. Braun Medical’s manufacturing site and distribution center in Daytona Beach were not seriously impacted by the hurricane, said company spokesperson Allison Longenhagen. No injuries to employees have been reported.

The center produces about 23% of the country’s IV fluids.

The company, with help from the federal government, had moved more than 60 truckloads of IV solutions inventory north of Florida before the storm. Longenhagen said that will they will be returned to the distribution site.

The federal Administration for Strategic Preparedness and Response helped coordinate trucks and drivers for the temporary move, which involved nearly 1.5 million bags of solution, a representative said Thursday.

The factory is seen as an important source of sterile intravenous, or IV, fluid supplies that had grown tight after Hurricane Helene hit Florida and several other states late last month. That storm forced Baxter International to shut down a North Carolina factory that makes about 60% of the country’s IV fluid supply.

That plant also makes fluids used by patients on home kidney dialysis.

Baxter started limiting customer orders after that storm to stretch supplies. Health systems, in turn, also started to conserve IV fluids and delay some non-emergency surgeries.

Baxter said Wednesday that it was increasing production at other locations and easing some limits it had placed on customer orders. The company also said in a statement posted on its website that it was working with the federal government to temporarily import products.

Baxter aims to restart production at its North Carolina plant in phases by the end of the year and possibly end limits for certain IV solutions by then, too.

In the meantime, the company said its limits would help curb stockpiling and increase equitable access.

B. Braun has said its Daytona Beach site was a key part of its plan to address the shutdown of Baxter’s North Carolina location. B. Braun also said it also was increasing production at a factory in Irvine, California.

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

Get the best of Indiana business news. ONLY $1/week Subscribe Now

Get the best of Indiana business news. ONLY $1/week Subscribe Now

Get the best of Indiana business news. ONLY $1/week Subscribe Now

Get the best of Indiana business news. ONLY $1/week Subscribe Now

Get the best of Indiana business news.

Limited-time introductory offer for new subscribers

ONLY $1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Get the best of Indiana business news.

Limited-time introductory offer for new subscribers

ONLY $1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Get the best of Indiana business news.

Limited-time introductory offer for new subscribers

ONLY $1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Get the best of Indiana business news.

Limited-time introductory offer for new subscribers

ONLY $1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In